Literature DB >> 3937341

Specific desensitization of the canine renal vasculature to angiotensin II despite cyclo-oxygenase inhibition.

L G Meggs, R W Katzberg, P DeLeeuw, N K Hollenberg.   

Abstract

Intrarenal angiotensin (AII) infusion results in a poorly sustained renal vasoconstrictor response. To examine the relationship between fade and renal tachyphylaxis to AII, sub-pressor doses of AII and norepinephrine (NE) were injected into the renal arteries of anesthetized dogs, resulting in a transient reduction (greater than 50 percent) in renal blood flow. Continuous intrarenal AII infusion, sufficient to reduce renal blood flow by 50 percent, followed. Within five minutes, despite continued AII infusion, substantial recovery (73 +/- 11 percent) of renal blood flow occurred; however, the response to AII bolus injection was lost, but that to NE was sustained. A second group of dogs received indomethacin (5 mg/kg intravenously) 30 minutes prior to the study; the reduction in renal blood flow was better sustained; however, renal tachyphylaxis was still evident.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3937341      PMCID: PMC2589940     

Source DB:  PubMed          Journal:  Yale J Biol Med        ISSN: 0044-0086


  18 in total

1.  Angiotensin receptors in vascular tissue.

Authors:  M A Devynck; P Meyer
Journal:  Am J Med       Date:  1976-11       Impact factor: 4.965

2.  Further studies on angiotensin tachyphylaxis.

Authors:  A Moore; P A Khairallah
Journal:  J Pharmacol Exp Ther       Date:  1976-06       Impact factor: 4.030

3.  Effects of prostaglandin synthesis inhibitors on angiotensin tachyphylaxis in the isolated coeliac and mesenteric arteries of the rabbit.

Authors:  J W Aiken
Journal:  Pol J Pharmacol Pharm       Date:  1974 Jan-Apr

4.  Intrarenal prostaglandin release attenuates the renal vasoconstrictor activity of angiotensin.

Authors:  J W Aiken; J R Vane
Journal:  J Pharmacol Exp Ther       Date:  1973-03       Impact factor: 4.030

5.  Release of a prostaglandin-like substance into renal venous blood in response to angiotensin II.

Authors:  J C McGiff; K Crowshaw; N A Terragno; A J Lonigro
Journal:  Circ Res       Date:  1970-07       Impact factor: 17.367

6.  Dependency of renal blood flow on prostaglandin synthesis in the dog.

Authors:  A J Lonigro; H D Itskovitz; K Crowshaw; J C McGiff
Journal:  Circ Res       Date:  1973-06       Impact factor: 17.367

Review 7.  Pharmacological receptors.

Authors:  D R Waud
Journal:  Pharmacol Rev       Date:  1968-06       Impact factor: 25.468

8.  Hormone interactions in the isolated rabbit heart. Synthesis and coronary vasomotor effects of prostaglandins, angiotensin, and bradykinin.

Authors:  P Needleman; G R Marshall; B E Sobel
Journal:  Circ Res       Date:  1975-12       Impact factor: 17.367

9.  Angiotensin antagonists with increased specificity for the renal vasculature.

Authors:  K J Taub; W J Caldicott; N K Hollenberg
Journal:  J Clin Invest       Date:  1977-03       Impact factor: 14.808

10.  Inhibition of bradykinin vasodilation and potentiation of norepinephrine and angiotensin vasoconstriction by inhibitors of prostaglandin synthesis in skeletal muscle of the rat.

Authors:  E J Messina; R Weiner; G Kaley
Journal:  Circ Res       Date:  1975-10       Impact factor: 17.367

View more
  2 in total

1.  Tachyphylaxis of juxtaglomerular epithelioid cells to angiotensin II. Differences between the electrical membrane response and renin secretion.

Authors:  C P Bührle; E Hackenthal; R Nobiling; O Skøtt; L Baumbach; R Taugner
Journal:  Pflugers Arch       Date:  1987-09       Impact factor: 3.657

Review 2.  Angiotensin receptor blockers in diabetic nephropathy.

Authors:  D A Price; N K Hollenberg
Journal:  Curr Diab Rep       Date:  2001-12       Impact factor: 4.810

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.